Tempest Therapeutics Inc. (NASDAQ: TPST) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TEMPEST THERAPEUTICS INC.

Tempest Therapeutics Inc. (NASDAQ: TPST)
Listen to this Section


$1.11
-0.0510 ( -4.40% ) 72.4K

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Market Data


Open $1.11
Previous Close $1.16
Volume 72.4K
Market Cap $17.18M
Day Range $1.10 - $1.24
52 Week Range $1.10 - $6.12
Shares Outstanding 14.81M
Change % -4.40%
Net Change ▼ -0.0510
Insider Ownership -0.15%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -2,038,328.00

Date Type Amount Purchased Purchaser
2024-01-05 Sale -26500.00 Trojanowski Justin
2024-01-05 Sale -40000.00 Maestas Nicholas
2023-10-13 Sale -100000.00 Maestas Nicholas
2023-10-13 Sale -725000.00 Brady Stephen R
2023-10-13 Sale -55000.00 Trojanowski Justin
2023-10-13 Sale -325000.00 Whiting Samuel

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Nov 05, 2025
10-q Quarterly Reports 60 Nov 05, 2025
8-k 8K-related 12 Aug 11, 2025
10-q Quarterly Reports 66 Aug 11, 2025
8-k 8K-related 17 Jun 12, 2025
8-k 8K-related 13 Jun 11, 2025
8-k 8K-related 13 Jun 06, 2025

Latest News